Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology
K. Zacharowski et al., Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology, ART THROM V, 19(9), 1999, pp. 2276-2280
Pretreatment of rats with small doses of lipopolysaccharide (LPS), eg, for
24 hours, attenuates the cardiac dysfunction caused by subsequent period of
myocardial ischemia. This phenomenon of enhanced tolerance to an ischemic
insult has been termed "second window of protection." Although the cardiopr
otective effects of LPS were first reported in 1989, it is still unclear wh
ether the observed attenuation by LPS of the ischemia-induced cardiac dysfu
nction is indeed secondary to the protection of cardiac myocytes against is
chemic cell injury and death. This study was designed to investigate the ef
fects of "preconditioning" with LPS on cell injury caused by regional myoca
rdial ischemia and reperfusion in the anesthetized rat. Thirty-five Wistar
rats were subjected to 25 minutes occlusion of the left anterior descending
coronary artery followed by 2 hours of reperfusion. Hemodynamic parameters
were continuously recorded, and at the end of the experiments, infarct siz
e (using p-nitro-blue tetrazolium staining), cardiac troponin T release, an
d histological markers of cell injury and death were determined. In rats pr
etreated with a bolus of saline (vehicle for LPS) 2 or 24 hours before left
anterior descending coronary artery occlusion and reperfusion, the infarct
size was 59+/-4% (2 hours saline-control, n=6) and 61+/-3% (24 hours salin
e-control, n=6), respectively. Pretreatment of animals with a bolus of LPS
(1 mg/kg IP) 24 hours before the onset of myocardial ischemia and reperfusi
on reduced both infarct size (to 18+/-7%; P<0.05, n=6) as well as histologi
cal signs of cell injury. Pretreatment (24 hours, as above) of rats with LP
S also reduced the release of cardiac troponin T from 58+/-13 ng/mL (saline
-control) to 16+/-9 ng/mL. In contrast, pretreatment of rats with LPS (2 ho
urs, as above) did not affect infarct size (56+/-8%, n=6), cardiac troponin
T release, or the histological parameters of cell injury. These data provi
de the first conclusive evidence that pretreatment of rats with a bolus of
LPS 24 hours before intervention reduces the cell injury and death caused b
y a subsequent period of myocardial ischemia and reperfusion.